Tumor necrosis factor-alpha and interleukin-1 alpha as predictors of survival in peritonitis: A pilot study

Tumor necrosis factor-alpha and interleukin-1 alpha as predictors of survival in peritonitis: A pilot study

Context: Peritonitis induces an inflammatory response characterized by the elevation of various cytokine levels. Included in this cascade of cytokines are tumor necrosis factor-alpha (TNF-α) and interleukin-1 alpha (IL-1α). The outcome of patient care may be associated with the pattern of elaboratio...

Full description

Bibliographic Details
Main Authors:	Oludolapo Ola Afuwape, Omobolaji O Ayandipo, Modupe Kuti, T A Adigun, O K Idowu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Nigerian Journal of Surgery
Subjects:	Cytokines outcome peritonitis
Online Access:	http://www.nigerianjsurg.com/article.asp?issn=1117-6806;year=2018;volume=24;issue=2;spage=107;epage=110;aulast=Afuwape

Similar Items

Factors associated with mortality in patients with peritonitis presenting for anesthesia and surgery in a tertiary center in Nigeria - A cross-sectional study
by: Tinuola Abiodun Adigun, et al.
Published: (2020-01-01)

Base excess and pH as predictors of outcomes in secondary peritonitis in a resource limited setting - A prospective study
by: O Oludolapo Afuwape, et al.
Published: (2020-01-01)

Usefulness of the alpha maneuver in the peritoneal catheter displacement: Review and experience
by: Laura del Río García, et al.
Published: (2020-09-01)

Eryptosis in Peritoneal Dialysis-Related Peritonitis: The Potential Role of Inflammation in Mediating the Increase in Eryptosis in PD
by: Grazia Maria Virzì, et al.
Published: (2022-11-01)

Pattern of presentation and outcome of management of acute appendicitis: A 10-year experience
by: Oludolapo O Afuwape, et al.
Published: (2018-01-01)

Evaluation of Biomarkers from Peritoneal Fluid as Predictors of Severity for Abdominal Sepsis Patients Following Emergency Laparotomy
by: Zhao J, et al.
Published: (2023-02-01)

Study of serum cytokines (interleukin-6 and tumor necrosis factor-alpha) in acute leukemias
by: Divita Saxena, et al.
Published: (2022-01-01)

ALPHA–LIPOIC ACID ANTIOXIDANT EFFICIENCY IN TREATMENT OF PERITONEAL DIALYSIS PATIENTS
by: L. Korol, et al.
Published: (2015-01-01)

Role of cytokines in the pathogenesis of diffuse bacterial peritonitis
by: E. E. Chepurnykh, et al.
Published: (2016-07-01)

Effects of Force Constancy on the Distribution of Interleukin-1 Beta and Tumor Necrosis Factor-Alpha Levels
by: Belma Işık Aslan, et al.
Published: (2013-03-01)

Peritoneal dialysis and peritoneal fibrosis: molecular mechanisms, risk factors and prospects for prevention
by: N. Stepanova, et al.
Published: (2022-06-01)

PROGNOSTIC VALUE OF INTERLEUKIN-6 IN VARIOUS BIOLOGICAL ENVIRONMENTS IN GENERALIZED PERITONITIS
by: N. J. Gadzhiev
Published: (2018-01-01)

CYTOKINE EXPRESSION PROFILES OF PERITONEAL FLUID IN THE PATIENTS WITH UTERINE LEIOMYOMA
by: K. A. Syssoev, et al.
Published: (2014-07-01)

Stage-specific five-year survival outcomes in women treated for early stage breast cancer in Ibadan, Nigeria
by: Omobolaji O Ayandipo, et al.
Published: (2020-01-01)

Diathermy versus scalpel incision in a heterogeneous cohort of general surgery patients in a Nigerian teaching hospital
by: Omobolaji O Ayandipo, et al.
Published: (2015-01-01)

Neuroprotective Effect of Vinpocetine against Lead Acetate-Instigated Neurotoxicity in Rats by Evaluation Tumor Necrosis Factor-Alpha, Interleukin-1Beta and Interleukin-10
by: Manal Abdulkhaliq Ibrahim, et al.
Published: (2022-12-01)

Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
by: Michela Terri, et al.
Published: (2021-03-01)

Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy
by: Riikka Havunen, et al.
Published: (2017-03-01)

Increased tumor necrosis factor alpha and interleukin-6 serum levels and their correlation with laboratory parameters in patients with imported malaria
by: Poluga Jasmina, et al.
Published: (2012-01-01)

Increased Serum Interleukin-6 and Tumor Necrosis Factor Alpha Levels in Fabry Disease: Correlation with Disease Burden
by: Nilton Salles Rosa Neto, et al.
Published: (2021-07-01)

Independent Associations of Tumor Necrosis Factor-Alpha and Interleukin-1 Beta With Radiographic Emphysema in People Living With HIV
by: Rebekka F. Thudium, et al.
Published: (2021-04-01)

Peritonitis difusas: Actualización y tratamiento
by: Rosalba Roque González, et al.
Published: (2000-08-01)

Interleukin-8 and tumor necrosis factor-alpha in youth with mood disorders—A longitudinal study
by: Maria Skibinska, et al.
Published: (2022-08-01)

Preditores de peritonite em pacientes em um programa de diálise peritoneal Predictor factors of peritoneal dialysis-related peritonitis
by: João Victor Duarte Lobo, et al.
Published: (2010-06-01)

The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival
by: Kumboyono K, et al.
Published: (2022-03-01)

The Study of Serum Level of Interleukin-2, Interleukin-6, and Tumor Necrosis Factor-alpha in Stable and Progressive Vitiligo Patients from Sina Hospital in Tabriz, Iran
by: Mohammad Reza Ranjkesh, et al.
Published: (2021-01-01)

Peritoneal Dialysis-Associated Peritonitis
by: Funda TİMURKAYNAK
Published: (2006-09-01)

The effectiveness of the use of various options for drainage of the abdominal cavity in creating a model of chronic peritonitis and the determination of indicators of total peritoneal fibrosis
by: A. B. Kebkalo, et al.
Published: (2019-09-01)

Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients
by: Yi-Hsin Chou, et al.
Published: (2022-02-01)

Characterization of CPH:SA microparticle‐based delivery of interleukin‐1 alpha for cancer immunotherapy
by: M. M. Hasibuzzaman, et al.
Published: (2023-05-01)

Levels of cytokines in extended purulent peritonitis and methods of immunocorrection
by: E. T. Mammadova
Published: (2020-12-01)

The Effect of Phototherapy on Serum Level of Tumor Necrosis Factor Alpha in Neonates
by: Mohamed Neam, et al.
Published: (2020-01-01)

The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival [Corrigendum]
by: Kumboyono K, et al.
Published: (2023-06-01)

Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
by: Toledo JO, et al.
Published: (2015-01-01)

Encapsulating Peritoneal Sclerosis and its Treatment
by: Rümeyza Kazanc›o¤lu
Published: (2010-09-01)

LEVELS OF TUMOR NECROSIS FACTOR ALPHA IN PATIENTS WITH ISCHEMIC STROKE
by: I. A. Prilutskaya, et al.
Published: (2019-10-01)

Association of Tumor Necrosis Factor-Alpha, Interleukin-1β, Interleukin-8, and Interferon-γ with Obstructive Sleep Apnea in Both Children and Adults: A Meta-Analysis of 102 Articles
by: Amin Golshah, et al.
Published: (2024-03-01)

Clinical Characteristics of Enterococcus-Associated Peritonitis in Patients with Peritoneal Dialysis
by: Ni J, et al.
Published: (2023-05-01)

Predictors of peritoneal dialysis associated peritonitis; application of the zero-inflated negative binomial model
by: Shahrokh Ezzatzadegan Jahromi, et al.
Published: (2019-10-01)

Novel Predictors and Risk Score of Treatment Failure in Peritoneal Dialysis-Related Peritonitis
by: Xiang Liu, et al.
Published: (2021-03-01)